Literature DB >> 6815656

Cloning and sequence determination of the gene for the human immunoglobulin epsilon chain expressed in a myeloma cell line.

J H Kenten, H V Molgaard, M Houghton, R B Derbyshire, J Viney, L O Bell, H J Gould.   

Abstract

Messenger RNA has been isolated from cells of the human myeloma line 266BL which synthesizes IgE of the myeloma ND. A fraction enriched in mRNA for the epsilon heavy chain was copied into DNA and the DNA was cloned in Escherichia coli. A chemically synthesized oligonucleotide probe, based on the experimentally determined sequence of the specific message, was used to screen colonies. The largest epsilon chain cDNA cloned, 2.0 kilobases, was characterized by restriction endonuclease mapping and DNA sequence analysis. It appears to encode the complete amino acid sequence of the epsilon chain, including a signal peptide at the NH2 terminus as well as untranslated sequences at the 5' and 3' ends of the mRNA. The missing part of the previously published amino acid sequence of the ND epsilon chain was determined from the DNA sequence.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6815656      PMCID: PMC347188          DOI: 10.1073/pnas.79.21.6661

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Properties of myeloma immunoglobulin E(Yu). Chemical, fluorescence polarisation and spin-labeled studies.

Authors:  R S Nezlin; Y A Zagyansky; A I Käiväräinen; D V Stefani
Journal:  Immunochemistry       Date:  1973-10

2.  Immunological studies of an atypical (myeloma) immunoglobulin.

Authors:  S G Johansson; H Bennich
Journal:  Immunology       Date:  1967-10       Impact factor: 7.397

3.  Characteristics of established myeloma and lymphoblastoid cell lines derived from an E myeloma patient: a comparative study.

Authors:  K Nilsson
Journal:  Int J Cancer       Date:  1971-05-15       Impact factor: 7.396

4.  Clinical aspects of IgE myeloma.

Authors:  M Ogawa; S Kochwa; C Smith; K Ishizaka; O R McIntyre
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

5.  Properties of a supercoiled deoxyribonucleic acid-protein relaxation complex and strand specificity of the relaxation event.

Authors:  D B Clewell; D R Helinski
Journal:  Biochemistry       Date:  1970-10-27       Impact factor: 3.162

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient.

Authors:  K Nilsson; H Bennich; S G Johansson; J Pontén
Journal:  Clin Exp Immunol       Date:  1970-10       Impact factor: 4.330

8.  Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA.

Authors:  S N Cohen; A C Chang; L Hsu
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

9.  Biosynthesis of the carbohydrate portion of immunoglobulins. Kinetics of synthesis and secretion of [3H] leucine-, [3H] galactose- and [3H] mannose-labelled myeloma protein by two plasma-cell tumours.

Authors:  F Melchers
Journal:  Biochem J       Date:  1970-10       Impact factor: 3.857

10.  Immunoglobulin M biosynthesis. Production of intermediates and excess of light-chain in mouse myeloma MOPC 104E.

Authors:  R M Parkhouse
Journal:  Biochem J       Date:  1971-07       Impact factor: 3.857

View more
  15 in total

1.  Growth inhibition of murine mammary carcinoma by monoclonal IgE antibodies specific for the mammary tumor virus.

Authors:  E Nagy; I Berczi; A H Sehon
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Expression and secretion of aequorin as a chimeric antibody by means of a mammalian expression vector.

Authors:  J Casadei; M J Powell; J H Kenten
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

3.  Blocking of passive sensitization of human mast cells and basophil granulocytes with IgE antibodies by a recombinant human epsilon-chain fragment of 76 amino acids.

Authors:  B Helm; D Kebo; D Vercelli; M M Glovsky; H Gould; K Ishizaka; R Geha; T Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  Expression of a biologically active fragment of human IgE epsilon chain in Escherichia coli.

Authors:  F T Liu; K A Albrandt; C G Bry; T Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

5.  Properties of a human immunoglobulin epsilon-chain fragment synthesized in Escherichia coli.

Authors:  J Kenten; B Helm; T Ishizaka; P Cattini; H Gould
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

6.  Molecular cloning and nucleotide sequencing of human immunoglobulin epsilon chain cDNA.

Authors:  M Seno; T Kurokawa; Y Ono; H Onda; R Sasada; K Igarashi; M Kikuchi; Y Sugino; Y Nishida; T Honjo
Journal:  Nucleic Acids Res       Date:  1983-02-11       Impact factor: 16.971

7.  Expression of human immunoglobulin E epsilon chain cDNA in E. coli.

Authors:  T Kurokawa; M Seno; R Sasada; Y Ono; H Onda; K Igarashi; M Kikuchi; Y Sugino; T Honjo
Journal:  Nucleic Acids Res       Date:  1983-05-25       Impact factor: 16.971

8.  Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1984-01-25       Impact factor: 16.971

9.  Specific inhibition of IgE antibody production by an antisense oligodeoxynucleotide oligomer (Oligostick).

Authors:  T J Hall; J Brostoff
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

10.  Biological properties of a recombinant human immunoglobulin epsilon-chain fragment.

Authors:  T Ishizaka; B Helm; J Hakimi; J Niebyl; K Ishizaka; H Gould
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.